How Merck uses patents to help maintain Keytruda’s exorbitant price
Explore the U.S. patents Merck deploys to stymie competition and keep revenues for its blockbuster cancer drug flowing as long as possible. …
Explore the U.S. patents Merck deploys to stymie competition and keep revenues for its blockbuster cancer drug flowing as long as possible. …
As bureaucratic fights to access Keytruda drag on for years, some patients die waiting. …
Desperate patients — and even hospitals — have become unwitting customers of fake Keytruda, with potentially fatal consequences. …
The pharmaceutical giant has built a fortress of patents, traded in secrecy and relentlessly lobbied to guard its revenue kingpin Keytruda. …
A few weeks ago, Viktor Orbán reminisced about the election of the current American president before a cheering crowd at a conference in Budapest organized…
Everyone loves to win awards. But what does it mean to reward good journalism?
The post Rethinking journalism awards appeared first on Lighthouse Reports. …